Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
COPENHAGEN (Reuters) -Novo Nordisk (NVO) has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small...
Read moreDetailsLatest Post
Calgary researchers discover that life has a literal glow
“We try to be very meticulous and scientific around it, but as soon as you talk about this there’s a...
Read moreDetails
Bolivia ambassador concerned over Israel’s ‘colonialism and genocidal actions’
Bolivian ambassador to the Netherlands, Roberto Calzadilla Sarmiento, spoke to Middle East Eye on 30 April outside the International Court...
Read moreDetails
Ulta Beauty CFO’s journey to the C-suite began with a summer job on Wall Street at 16 todayheadline
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use...
Read moreDetailsPlus Therapeutics reports progress in CNS cancer therapy todayheadline
Plus Therapeutics reports progress in CNS cancer therapy
Read moreDetails
